“Our echocardiographic findings at discharge and at follow-up, obtained at rest, were consistent with satisfactory hemodynamic properties of the Mitroflow pericardial valve, particularly in small sizes, and confirmed excellent and constant hemodynamic performances in the majority of the patients also at long term, in accordance to the findings of Yankah and colleagues”

Clinical results

Conclusions

“This study indicates that the Mitroflow pericardial valve provides favorable postoperative results at long term in terms of valve durability, valve-related events and patient clinical conditions. Furthermore, good hemodynamic performance can be expected postoperatively, even in the presence of small prosthetic sizes, therefore representing, in our opinion, an extremely valuable bioprosthesis in case of planned aortic valve replacement with a tissue valve, particularly for patients older than 70 years or in the presence of a small aortic annulus.”

Hemodynamic results

Clinical results

Conclusions

“The Mitroflow pericardial bioprosthesis exhibits very low pressure gradients combined with easy implantability. After two decades of follow-up, the Mitroflow pericardial aortic valve continues to be a valve of choice with a predictable low rate of valve-related events, particularly for patients over the age of 65 -70 and others with comorbidities.”